Indications of liver transplantation in patients with complications of cirrhosis
- PMID: 17223504
- DOI: 10.1016/j.bpg.2006.07.007
Indications of liver transplantation in patients with complications of cirrhosis
Abstract
Transplantation is the only option for reversing liver insufficiency and its complications in patients with end-stage cirrhosis. Transplantation is generally considered after the first episode of decompensation of cirrhosis, provided no specific intervention can result in a longstanding return to the compensated state. Alcohol abuse and hepatitis C virus infection are the predominant causes leading to transplantation in Western countries. In cases of alcoholic cirrhosis, a 6-month period of abstinence is needed before transplantation. Patients with hepatitis C virus infection are considered independent of viral replication, even if post-transplantation recurrence is almost constant. Conversely, in cases of hepatitis B infection, only patients without viral replication (or with extremely low viral load) are suitable candidates. Hepatocellular carcinoma represents an increasing proportion of the indications and offers excellent long-term survival. However, transplantation should be limited to patients with small tumours. HIV infection no longer represents a definitive contraindication.
Similar articles
-
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735. Liver Transpl. 2009. PMID: 19718643
-
[Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].An Sist Sanit Navar. 2004;27 Suppl 2:91-101. An Sist Sanit Navar. 2004. PMID: 15381947 Review. Spanish.
-
Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.Transplant Proc. 2007 Oct;39(8):2511-3. doi: 10.1016/j.transproceed.2007.07.023. Transplant Proc. 2007. PMID: 17954160
-
Liver transplantation in HIV/hepatitis co-infection.J HIV Ther. 2007 Mar;12(1):24-35. J HIV Ther. 2007. PMID: 17589393 Review.
-
The natural history of hepatitis C cirrhosis after liver transplantation.Liver Transpl. 2009 Sep;15(9):1063-71. doi: 10.1002/lt.21784. Liver Transpl. 2009. PMID: 19718647
Cited by
-
Stem cells for end stage liver disease: how far have we got?World J Gastroenterol. 2008 Aug 7;14(29):4593-9. doi: 10.3748/wjg.14.4593. World J Gastroenterol. 2008. PMID: 18698672 Free PMC article. Review.
-
SDF-1/CXCR4 Axis Promotes MSCs to Repair Liver Injury Partially through Trans-Differentiation and Fusion with Hepatocytes.Stem Cells Int. 2015;2015:960387. doi: 10.1155/2015/960387. Epub 2015 Aug 2. Stem Cells Int. 2015. PMID: 26300925 Free PMC article.
-
Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation.Stem Cell Res Ther. 2017 Jun 5;8(1):131. doi: 10.1186/s13287-017-0575-5. Stem Cell Res Ther. 2017. PMID: 28583205 Free PMC article.
-
Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.World J Gastroenterol. 2015 Jan 21;21(3):742-58. doi: 10.3748/wjg.v21.i3.742. World J Gastroenterol. 2015. PMID: 25624709 Free PMC article. Review.
-
The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications.Int J Mol Sci. 2019 Oct 23;20(21):5266. doi: 10.3390/ijms20215266. Int J Mol Sci. 2019. PMID: 31652839 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical